Keep up to date with what we're working on!
Bionova Scientific adds experienced biopharma CFO and VP of Quality to help drive growth
Fremont, CA Sept 9th, 2019 – Bionova Scientific, a CDMO providing mammalian development and manufacturing services, announces the addition of Mr. Kyung Lee as Chief Financial Officer. The Company also announced the addition of Mr. Eric Fulmer as Vice President of QA. Bionova Scientific is a portfolio company of Great Point Partners, a leading health care investment firm.
Mr. Lee comes to Bionova Scientific with a long career of successful biopharma finance leadership experience, having spent 8 years as the Director of Finance for Boehringer Ingelheim’s Fremont site. Previously, Mr. Lee was the Director of Finance at Amgen Fremont and also held senior finance roles at Abgenix.
Mr. Fulmer joins Bionova with an extensive background in biopharmaceutical quality operations. Mr. Fulmer was most recently the Director of Quality at Samsung Biologics. Prior to Samsung, Mr. Fulmer was a Senior Manager of Quality Assurance at Amgen.
Amy Kong, the CEO of Bionova Scientific, commented:
“The addition of Kyung and Eric to the Bionova Scientific executive management team will help Bionova accelerate future growth and add significant biopharma leadership experience to Bionova. The collective experiences of Kyung and Eric will bring invaluable expertise and, along with our new facilities and expanded capabilities, will help Bionova Scientific deliver more value to our existing and future partners.”